The latest breaking e-mail from the CDC, American Academy of Pediatrics, and American Academy of Family Physicians:
Chiron Corp., manufacturer of the influenza vaccine Fluvirin, announced today it is unable to release flu vaccine for at least 3 months. Fluvirin, which is manufactured in England, accounted for almost 50 percent of the total US influenza vaccine supply. It is approved for adults and children ages four and above.
The AAP, the American Academy of Family Physicians and the Centers for Disease Control and Prevention agreed on guidelines for physicians. The following high-risk groups (of equal priority) are to receive flu vaccine:
Children 6 through 23 months of age.
Adults 65 years of age and older.
People 24 months - 64 years of age with chronic medical conditions.
Women pregnant during the flu season.
Residents of chronic care facilities.
Children on chronic aspirin therapy.
Healthcare workers with direct patient contact.
Household contacts and out-of-home caregivers of children 0-6 months of age.
Children under 9 years of age require two doses if they have not been previously vaccinated. All children at high risk of complications from influenza who present for vaccination should be vaccinated with a first or second dose depending on vaccination status. However, doses should not be held in reserve to ensure that two doses will be available. Rather, available vaccine should be used to vaccinate on a first-come, first-served basis.
FluMist is appropriate for those health care workers not in contact with severely immunocompromised persons and those healthy individuals 5-49 years of age in close contact with infants 0-6 months of age.
Chiron Corp., manufacturer of the influenza vaccine Fluvirin, announced today it is unable to release flu vaccine for at least 3 months. Fluvirin, which is manufactured in England, accounted for almost 50 percent of the total US influenza vaccine supply. It is approved for adults and children ages four and above.
The AAP, the American Academy of Family Physicians and the Centers for Disease Control and Prevention agreed on guidelines for physicians. The following high-risk groups (of equal priority) are to receive flu vaccine:
Children 6 through 23 months of age.
Adults 65 years of age and older.
People 24 months - 64 years of age with chronic medical conditions.
Women pregnant during the flu season.
Residents of chronic care facilities.
Children on chronic aspirin therapy.
Healthcare workers with direct patient contact.
Household contacts and out-of-home caregivers of children 0-6 months of age.
Children under 9 years of age require two doses if they have not been previously vaccinated. All children at high risk of complications from influenza who present for vaccination should be vaccinated with a first or second dose depending on vaccination status. However, doses should not be held in reserve to ensure that two doses will be available. Rather, available vaccine should be used to vaccinate on a first-come, first-served basis.
FluMist is appropriate for those health care workers not in contact with severely immunocompromised persons and those healthy individuals 5-49 years of age in close contact with infants 0-6 months of age.